Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Breast care, 17.2021, 2, S. 199-207
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2021
- Urheber
-
Rhiem, Kerstin E. M.
Auber, Bernd
Briest, Susanne
Dikow, Nicola
Ditsch, Nina
Dragicevic, Neda
Grill, Sabine
Hahnen, Eric Thomas
Horváth, Judit
Jäger, Bernadette
Kast, Karin
Kiechle, Marion
Leinert, Elena
Morlot, Susanne
Püsken, Michael
Schäfer, Dieter
Schott, Sarah
Schroeder, Christopher Maximilian
Siebers-Renelt, Ulrike
Solbach, Christine
Weber-Lassalle, Nana-Maureen
Witzel, Isabell
Zeder-Göß, Christine
Schmutzler, Rita
- DOI
-
10.1159/000516376
- URN
-
urn:nbn:de:hebis:30:3-629304
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:57 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rhiem, Kerstin E. M.
- Auber, Bernd
- Briest, Susanne
- Dikow, Nicola
- Ditsch, Nina
- Dragicevic, Neda
- Grill, Sabine
- Hahnen, Eric Thomas
- Horváth, Judit
- Jäger, Bernadette
- Kast, Karin
- Kiechle, Marion
- Leinert, Elena
- Morlot, Susanne
- Püsken, Michael
- Schäfer, Dieter
- Schott, Sarah
- Schroeder, Christopher Maximilian
- Siebers-Renelt, Ulrike
- Solbach, Christine
- Weber-Lassalle, Nana-Maureen
- Witzel, Isabell
- Zeder-Göß, Christine
- Schmutzler, Rita
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2021
Ähnliche Objekte (12)
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Germline RAD51C mutations confer susceptibility to ovarian cancer
PET-CT in recurrent ovarian cancer: impact on treatment planning
Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Untersuchung zur Wirkung eines Pflanzenextrakts „Petroselinum crispum subsp. tuberosum“ auf humane benigne und maligne Mammaepithelzellen (MCF-7 und MCF-12a)
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Germline RAD51C mutations confer susceptibility to ovarian cancer
PET-CT in recurrent ovarian cancer: impact on treatment planning
Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Untersuchung zur Wirkung eines Pflanzenextrakts „Petroselinum crispum subsp. tuberosum“ auf humane benigne und maligne Mammaepithelzellen (MCF-7 und MCF-12a)
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Germline RAD51C mutations confer susceptibility to ovarian cancer
PET-CT in recurrent ovarian cancer: impact on treatment planning
Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores